Table 2 Transfer of risks between the Japanese and the UK population using weighting between a generalized ERR and EAR model according to ICRP 103 [19] and UNSCEAR [20].
Site | β ERR /β EAR - Japan | β ERR /β EAR - UK | w ERR /w EAR | β weighted - UK/ β EAR - Japan |
|---|---|---|---|---|
All solid | 1.14/1.00 | 1.95/0.91 | 0.5/0.5 | 1.43 |
Female breast | 1.04/1.00 | 2.88/0.89 | 0/1 | 0.89 |
Lung | 1.46/1.00 | 1.56/0.87 | 0.3/0.7 | 1.07 |
Rectum† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |
Colon | 0.96/1.00 | 0.92/0.93 | 0.5/0.5 | 0.92 |
Mouth and pharynx† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |
Esophagus | 8.20/1.00 | 10.0/1.00 | 0.5/0.5 | 5.50 |
Stomach | 0.69/1.00 | 0.13/0.97 | 0.5/0.5 | 0.55 |
Small Intestine† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |
Liver | 2.03/1.00 | 0.19/0.93 | 0.5/0.5 | 0.56 |
Cervix† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |
Bladder 1 | 0.95/1.00 | 1.59/0.82 | 0.5/0.5 | 1.20 |
Bladder 2 | 0.95/1.00 | 1.59/0.82 | 0.5/0.5 | 1.20 |
Skin† | 1.01/1.00 | 1.70/0.90 | 1/0 | 1.30 |
Brain and CNS | 0.94/1.00 | 1.76/1.00 | 0.5/0.5 | 1.38 |
Thyroid | 0.45/1.00 | 0.35/0.98 | 1/0 | 0.35 |
Salivary Gland† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |
Bone | 39.0/1.00 | 48.0/1.00 | 0/1 | 1.00 |
Soft tissue† | 1.01/1.00 | 1.70/0.90 | 0.5/0.5 | 1.30 |